NewsMarkets

Health

Gene Therapy From Chinese Firm HuidaGene Linked to Boy's Death

A therapy pioneered by the biotechnology firm showed promise in animals but caused a fatal reaction in a child.

2 publishers · 2 articles · first seen 27 Oct 2026 · updated 1h ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

The story so far

2 publishers have covered this in 2 articles since 27 Oct 2026. Nature published first, on 27 October at 00:00 UTC; News - South China Morning Post followed 37h 00m later. The most recent article, from News - South China Morning Post, appeared on 28 October at 13:00 UTC.

Outlets reporting it: Nature (major outlet), News - South China Morning Post.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Gene therapy that led to boy’s death had limited efficacy Nature ·
  2. In China gene-editing trial, 2 children improved, 1 died and 1 withdrew News - South China Morning Post

In this story

  • HuidaGene
Embed this story

Paste this into any web page to show the live odds, with a link back here.